A Study of NTX-1472 in Social Anxiety Disorder

Clinical trial NCT07323784 · RECRUITING

Trial details

NCT number: NCT07323784
Sponsor: Newleos Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Social Anxiety Disorder (SAD)

Start date: 2025-12-09
Primary completion: 2027-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.